NCT04030429 2025-07-16Crizotinib in c-MET Mutation Metastatic/Recurrent/Persistent Endometrial CancerNational Cheng-Kung University HospitalPhase 2 Terminated40 enrolled
NCT03485729 2024-12-24ONC201 in Recurrent or Metastatic Type II Endometrial Cancer Endometrial CancerJazz PharmaceuticalsPhase 2 Terminated27 enrolled 11 charts